What were these places thinking?
The company's acquisition of Surgical Care Affiliates is likely to be the center of attention.
Shares of Johnson & Johnson are poised for a rally as the stock is currently trading about 8% off its 52-week high.
The drug maker's shares have fallen 6.2% since Wednesday's market open.
An appeals court in Indiana upheld Eli Lilly's patent regarding Alimta, a major cancer drug for Lilly, keeping Teva and other generic drug specialists at bay.